Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep-Oct;12(5):445-55.
doi: 10.1016/j.acap.2012.04.009. Epub 2012 Jun 28.

Development of an instrument to measure parents' preferences and goals for the treatment of attention deficit-hyperactivity disorder

Affiliations

Development of an instrument to measure parents' preferences and goals for the treatment of attention deficit-hyperactivity disorder

Alexander G Fiks et al. Acad Pediatr. 2012 Sep-Oct.

Abstract

Objectives: To describe the development and validation of an instrument to measure parents' attention deficit-hyperactivity disorder (ADHD) treatment preferences and goals.

Methods: Parents of children 6 to 12 years of age diagnosed with ADHD in the past 18 months were recruited from 8 primary care sites and an ADHD treatment center (autism excluded). A 16-item medication, 15-item behavior therapy preference scale and a 23-item goal scale, were developed after a review of the literature, 90 parent and clinician semistructured interviews, and input from parent advocates and professional experts were administered to parents. Parent cognitive interviews confirmed item readability, clarity, content, and response range. We conducted an exploratory factor analysis and assessed internal consistency and test-retest reliability and construct and concurrent validity.

Results: We recruited 237 parents (mean child age 8.1 years, 51% black, 59% from primary care, 61% of children medication naive). Factor analyses identified 4 medication preference subscales (treatment acceptability, feasibility, stigma, and adverse effects, Cronbach's α 0.74-0.87); 3 behavior therapy subscales (treatment acceptability, feasibility, and adverse effects, α 0.76-0.83); and 3 goal subscales (academic achievement, behavioral compliance, and interpersonal relationships, α 0.83-0.86). The most strongly endorsed goal was academic achievement. The scales demonstrated construct validity, concurrent validity (r = 0.3-0.6) compared with the Treatment Acceptability Questionnaire and Impairment Rating Scale and moderate to excellent test-retest reliability (intraclass coefficient = 0.7-0.9).

Conclusions: We developed a valid and reliable instrument for measuring preferences and goals for ADHD treatment, which may help clinicians more easily comply with new national treatment guidelines for ADHD that emphasize shared decision making.

PubMed Disclaimer

Conflict of interest statement

Financial Disclosure and Conflicts of Interest: None.

Figures

Figure 1
Figure 1
Instructions and Format for the ADHD Preference and Goal Instrument. ©2012 The Children’s Hospital of Philadelphia. All Rights Reserved.

Similar articles

Cited by

References

    1. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango) Soc Sci Med. 1997;44(5):681–692. - PubMed
    1. O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;(3) CD001431. - PubMed
    1. Institute of Medicine (U.S.) Initial National Priorities for Comparative Effectiveness Research. Washington, D.C.: National Academy Press; 2009. Committee on Comparative Effectiveness Research Prioritization.
    1. The Patient Protection and Affordable Care Act. Public Law No:111-148, 124 Stat 1025; 111th Congress; United States of America. 2010.
    1. Mental Health in the United States: Prevalence of Diagnosis and Medication Treatment for Attention-Deficit/Hyperactivity Disorder --- United States, 2003. MMWR. 2005;54(34):842–847. - PubMed

Publication types